Long-term effects of weight-reducing interventions in hypertensive patients: systematic review and meta-analysis
- PMID: 18362248
- DOI: 10.1001/archinte.168.6.571
Long-term effects of weight-reducing interventions in hypertensive patients: systematic review and meta-analysis
Abstract
Weight loss is recommended in all major guidelines for antihypertensive therapy. We searched for randomized controlled trials investigating the effects of weight-reducing diets, pharmacologic substances, and invasive interventions for weight reduction on patient-relevant end points and blood pressure (BP) in patients with essential hypertension. No information on the effects on patient-relevant end points was available. Patients assigned to weight loss diets, orlistat, or sibutramine reduced their body weight more effectively than did patients in the usual care/placebo groups. Reduction of BP was higher in patients treated with weight loss diets (systolic BP [SBP]: weighted mean difference [WMD], -6.3 mm Hg; diastolic BP [DBP]: WMD, -3.4 mm Hg) or orlistat (SBP: WMD, -2.5 mm Hg; DBP: WMD, -2.0 mm Hg). Systolic BP increased with sibutramine treatment (WMD, 3.2 mm Hg). In patients with essential hypertension, therapy with a weight loss diet or orlistat resulted in reductions in body weight and BP. Although sibutramine treatment reduced body weight, it did not lower BP.
Similar articles
-
Long-term effects of weight-reducing drugs in hypertensive patients.Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007654. doi: 10.1002/14651858.CD007654.pub2. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007654. doi: 10.1002/14651858.CD007654.pub3. PMID: 19588440 Updated. Review.
-
Long-term effects of weight-reducing drugs in people with hypertension.Cochrane Database Syst Rev. 2016 Mar 2;3:CD007654. doi: 10.1002/14651858.CD007654.pub4. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2021 Jan 17;1:CD007654. doi: 10.1002/14651858.CD007654.pub5. PMID: 26934640 Updated. Review.
-
Long-term effects of weight-reducing drugs in hypertensive patients.Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007654. doi: 10.1002/14651858.CD007654.pub3. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2016 Mar 02;3:CD007654. doi: 10.1002/14651858.CD007654.pub4. PMID: 23543553 Updated. Review.
-
Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.J Hum Hypertens. 2002 Jan;16(1):5-11. doi: 10.1038/sj.jhh.1001298. J Hum Hypertens. 2002. PMID: 11840224 Clinical Trial.
-
Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.J Hum Hypertens. 2002 Jan;16(1):13-9. doi: 10.1038/sj.jhh.1001299. J Hum Hypertens. 2002. PMID: 11840225 Clinical Trial.
Cited by
-
The inverted U-shaped relationship between weight loss percentage and cardiovascular health scores.Eat Weight Disord. 2023 Oct 24;28(1):87. doi: 10.1007/s40519-023-01619-3. Eat Weight Disord. 2023. PMID: 37874416 Free PMC article.
-
The Influence of Dietary Interventions on Arterial Stiffness in Overweight and Obese Subjects.Nutrients. 2023 Mar 16;15(6):1440. doi: 10.3390/nu15061440. Nutrients. 2023. PMID: 36986170 Free PMC article. Review.
-
Translation and Cross-cultural Adaptation of the Self-care of Hypertension Inventory for Thais With Hypertension.J Cardiovasc Nurs. 2023 Mar-Apr 01;38(2):179-191. doi: 10.1097/JCN.0000000000000895. Epub 2022 Jan 31. J Cardiovasc Nurs. 2023. PMID: 35090153 Free PMC article.
-
Low-Calorie Ketogenic Diet with Continuous Positive Airway Pressure to Alleviate Severe Obstructive Sleep Apnea Syndrome in Patients with Obesity Scheduled for Bariatric/Metabolic Surgery: a Pilot, Prospective, Randomized Multicenter Comparative Study.Obes Surg. 2022 Mar;32(3):634-642. doi: 10.1007/s11695-021-05811-1. Epub 2021 Nov 20. Obes Surg. 2022. PMID: 34802065 Free PMC article. Clinical Trial.
-
A Cultural Dance Program Improves Hypertension Control and Cardiovascular Disease Risk in Native Hawaiians: A Randomized Controlled Trial.Ann Behav Med. 2021 Oct 4;55(10):1006-1018. doi: 10.1093/abm/kaaa127. Ann Behav Med. 2021. PMID: 33677520 Free PMC article. Clinical Trial.
